Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 9Unknown 3Terminated 3Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 7Neoplasms 3Medulloblastoma 3Brain Neoplasms 3Astrocytoma 3Recurrence 2Lymphoma, Follicular 2Glioma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Temozolomide 17Radiotherapy 5Bevacizumab 5Filgrastim 4vocimagene amiretrorepvec 3sargramostim 3etoposide phosphate 3antineoplaston AS 2-1 3antineoplaston A10 3Surgical Procedures, Operative 3O(6)-benzylguanine 3Melphalan 3Lomustine 3Flucytosine 3Dynamic Contrast Enhanced Magnetic Resonance Imaging 3Carmustine 3Aminolevulinic Acid 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3tovorafenib 2palbociclib 2cabozantinib 2Vorinostat 2Topotecan 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Perfusion Magnetic Resonance Imaging 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Astrocytoma × Lomustine × Clear all
NCT03022578 2022-08-10

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

M.D. Anderson Cancer Center

Phase 2 Terminated
7 enrolled 9 charts
CNS

Astrocytoma, Glioblastoma

NCT02414165 2020-02-07

Toca5

Tocagen Inc.

Phase 2/3 Terminated
403 enrolled
CNS

Astrocytoma, Glioblastoma, Recurrence

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡